S&P 500   4,585.31 (+0.79%)
DOW   36,120.53 (+0.18%)
QQQ   390.47 (+1.41%)
AAPL   194.14 (+0.95%)
MSFT   370.96 (+0.59%)
META   326.52 (+2.86%)
GOOGL   136.81 (+5.22%)
AMZN   146.63 (+1.46%)
TSLA   241.85 (+1.04%)
NVDA   464.82 (+2.15%)
NIO   7.49 (-3.35%)
BABA   72.35 (+1.20%)
AMD   127.92 (+9.50%)
T   17.08 (+0.83%)
F   10.83 (+1.31%)
MU   73.59 (+0.63%)
CGC   0.72 (+3.03%)
GE   119.04 (-0.64%)
DIS   92.36 (+0.94%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.47 (-1.78%)
XOM   98.33 (-0.79%)
S&P 500   4,585.31 (+0.79%)
DOW   36,120.53 (+0.18%)
QQQ   390.47 (+1.41%)
AAPL   194.14 (+0.95%)
MSFT   370.96 (+0.59%)
META   326.52 (+2.86%)
GOOGL   136.81 (+5.22%)
AMZN   146.63 (+1.46%)
TSLA   241.85 (+1.04%)
NVDA   464.82 (+2.15%)
NIO   7.49 (-3.35%)
BABA   72.35 (+1.20%)
AMD   127.92 (+9.50%)
T   17.08 (+0.83%)
F   10.83 (+1.31%)
MU   73.59 (+0.63%)
CGC   0.72 (+3.03%)
GE   119.04 (-0.64%)
DIS   92.36 (+0.94%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.47 (-1.78%)
XOM   98.33 (-0.79%)
S&P 500   4,585.31 (+0.79%)
DOW   36,120.53 (+0.18%)
QQQ   390.47 (+1.41%)
AAPL   194.14 (+0.95%)
MSFT   370.96 (+0.59%)
META   326.52 (+2.86%)
GOOGL   136.81 (+5.22%)
AMZN   146.63 (+1.46%)
TSLA   241.85 (+1.04%)
NVDA   464.82 (+2.15%)
NIO   7.49 (-3.35%)
BABA   72.35 (+1.20%)
AMD   127.92 (+9.50%)
T   17.08 (+0.83%)
F   10.83 (+1.31%)
MU   73.59 (+0.63%)
CGC   0.72 (+3.03%)
GE   119.04 (-0.64%)
DIS   92.36 (+0.94%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.47 (-1.78%)
XOM   98.33 (-0.79%)
S&P 500   4,585.31 (+0.79%)
DOW   36,120.53 (+0.18%)
QQQ   390.47 (+1.41%)
AAPL   194.14 (+0.95%)
MSFT   370.96 (+0.59%)
META   326.52 (+2.86%)
GOOGL   136.81 (+5.22%)
AMZN   146.63 (+1.46%)
TSLA   241.85 (+1.04%)
NVDA   464.82 (+2.15%)
NIO   7.49 (-3.35%)
BABA   72.35 (+1.20%)
AMD   127.92 (+9.50%)
T   17.08 (+0.83%)
F   10.83 (+1.31%)
MU   73.59 (+0.63%)
CGC   0.72 (+3.03%)
GE   119.04 (-0.64%)
DIS   92.36 (+0.94%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.47 (-1.78%)
XOM   98.33 (-0.79%)

Cannara Biotech Stock Price, News & Analysis (OTCMKTS:CNBTF)

$0.61
0.00 (0.00%)
(As of 12/6/2023 ET)
Today's Range
$0.61
$0.61
50-Day Range
$0.60
$0.76
52-Week Range
$0.08
$0.20
Volume
N/A
Average Volume
33,127 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CNBTF Stock Price History

CNBTF Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Dan Buettner
Power Lunch
Hugh Son
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Liz Knueven
Elizabeth Gravier
Jasmin Suknanan
Benji Stawski
Pia Singh
China's Corporate Spy War
CNBC's Last Call Podcast
Morgan Chittum
Ari Weisbard
See More Headlines
Receive CNBTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannara Biotech and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
N/A
Current Symbol
OTCMKTS:CNBTF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Zohar Krivorot (Age 42)
    Founder, Pres, CEO & Director
  • Mr. Lennie Ryer CPA (Age 58)
    CPA, CA, CFE, VP of Fin. & CFO
  • Mr. Evan Morris
    Chief Operating Officer
  • Ms. Julia Bouvet
    Chief of Staff














CNBTF Stock Analysis - Frequently Asked Questions

How have CNBTF shares performed in 2023?

Cannara Biotech's stock was trading at $0.0733 at the beginning of the year. Since then, CNBTF shares have increased by 737.0% and is now trading at $0.6133.
View the best growth stocks for 2023 here
.

How do I buy shares of Cannara Biotech?

Shares of CNBTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:CNBTF) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -